SurModics Inc.+$0.72 $11.65 A Rodman & Renshaw analyst upgraded the shares to "market perform," saying the share price already reflects the risks the medical technology company is facing. (Ticker: SRDX)
about the writer
The Eden Prairie-based manufacturer says the company-wide software problems led to a quarterly loss and a 11.3% drop in sales.
Advertisement